| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/29/2023 | 20.74% | JP Morgan | $120 → $125 | Maintains | Overweight |
| 08/25/2023 | 25.57% | Benchmark | $118 → $130 | Maintains | Buy |
| 08/25/2023 | 30.4% | B of A Securities | $128 → $135 | Maintains | Buy |
| 08/25/2023 | 27.5% | Citigroup | $134 → $132 | Maintains | Buy |
| 08/09/2023 | 29.43% | Citigroup | $118 → $134 | Maintains | Buy |
| 07/12/2023 | 23.64% | B of A Securities | $127 → $128 | Maintains | Buy |
| 06/05/2023 | — | Bernstein | Initiates Coverage On | → Outperform | |
| 05/30/2023 | 22.67% | B of A Securities | $116 → $127 | Maintains | Buy |
| 05/26/2023 | 9.15% | UBS | $112 → $113 | Maintains | Buy |
| 05/26/2023 | 13.98% | Benchmark | $104 → $118 | Maintains | Buy |
| 05/26/2023 | 13.98% | Citigroup | $115 → $118 | Maintains | Buy |
| 03/01/2023 | -3.41% | JP Morgan | $85 → $100 | Upgrades | Neutral → Overweight |
| 02/27/2023 | 11.08% | Citigroup | $100 → $115 | Maintains | Buy |
| 11/18/2022 | 0.45% | Benchmark | $136 → $104 | Maintains | Buy |
| 11/18/2022 | 1.42% | HSBC | $122 → $105 | Maintains | Buy |
| 11/18/2022 | -3.41% | Citigroup | $98 → $100 | Maintains | Buy |
| 08/19/2022 | 31.36% | Benchmark | $145 → $136 | Maintains | Buy |
| 08/19/2022 | 35.23% | Citigroup | $132 → $140 | Maintains | Buy |
| 05/25/2022 | 17.84% | HSBC | $126 → $122 | Maintains | Buy |
| 03/14/2022 | — | JP Morgan | Downgrades | Overweight → Underweight | |
| 02/25/2022 | 9.15% | 86 Research | → $113 | Upgrades | Hold → Buy |
| 05/19/2021 | 34.26% | UBS | $133 → $139 | Maintains | Buy |
| 05/19/2021 | 13.98% | Macquarie | $124 → $118 | Maintains | Neutral |
| 05/19/2021 | 29.43% | CLSA | $159 → $134 | Maintains | Buy |
| 02/16/2021 | 49.72% | Barclays | $110 → $155 | Maintains | Overweight |
| 08/14/2020 | 402.27% | Benchmark | $435 → $520 | Maintains | Buy |
| 08/14/2020 | — | Daiwa Capital | Initiates Coverage On | → Buy | |
| 05/22/2020 | 334.66% | Barclays | $390 → $450 | Maintains | Overweight |
| 05/21/2020 | 348.18% | Nomura | $439 → $464 | Maintains | Buy |
| 05/20/2020 | 325% | CFRA | $380 → $440 | Maintains | Buy |
| 05/07/2020 | 276.7% | Barclays | $380 → $390 | Maintains | Overweight |
| 02/27/2020 | 300.85% | B of A Securities | $366 → $415 | Reiterates | → Buy |
| 02/24/2020 | 276.7% | Barclays | $360 → $390 | Maintains | Overweight |
| 12/04/2019 | 255.45% | Goldman Sachs | $300 → $368 | Upgrades | Neutral → Buy |
| 11/22/2019 | 238.07% | Nomura | $317 → $350 | Maintains | Buy |
| 11/22/2019 | 250.62% | Macquarie | → $363 | Initiates Coverage On | → Outperform |
| 10/31/2019 | 228.41% | Barclays | $320 → $340 | Maintains | Overweight |
| 09/09/2019 | 206.19% | Nomura | $288 → $317 | Maintains | Buy |
| 09/06/2019 | 214.88% | Citigroup | $301 → $326 | Maintains | Buy |
| 08/12/2019 | — | Goldman Sachs | Downgrades | Buy → Neutral | |
| 08/05/2019 | 165.24% | Jefferies | → $274.6 | Initiates Coverage On | → Buy |
| 05/20/2019 | 209.09% | Barclays | $300 → $320 | Maintains | Overweight |
| 05/14/2019 | 189.77% | Barclays | $275 → $300 | Maintains | Overweight |
| 01/14/2019 | 189.77% | Barclays | $270 → $300 | Upgrades | Equal-Weight → Overweight |
| 12/19/2018 | — | UBS | Upgrades | Neutral → Buy | |
| 12/06/2018 | 189.77% | Morgan Stanley | → $300 | Upgrades | Equal-Weight → Overweight |
| 11/16/2018 | 157.9% | Nomura | $265 → $267 | Maintains | Buy |
| 11/16/2018 | 160.79% | Barclays | $250 → $270 | Maintains | Equal-Weight |
| 09/21/2018 | — | Jefferies | Upgrades | Hold → Buy | |
| 08/30/2018 | 151.13% | Barclays | $275 → $260 | Maintains | Equal-Weight |
What is the target price for NetEase (NTES)?
The latest price target for NetEase (NASDAQ: NTES) was reported by JP Morgan on August 29, 2023. The analyst firm set a price target for $125.00 expecting NTES to rise to within 12 months (a possible 20.74% upside). 16 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for NetEase (NTES)?
The latest analyst rating for NetEase (NASDAQ: NTES) was provided by JP Morgan, and NetEase maintained their overweight rating.
When is the next analyst rating going to be posted or updated for NetEase (NTES)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of NetEase, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for NetEase was filed on August 29, 2023 so you should expect the next rating to be made available sometime around August 29, 2024.
Is the Analyst Rating NetEase (NTES) correct?
While ratings are subjective and will change, the latest NetEase (NTES) rating was a maintained with a price target of $120.00 to $125.00. The current price NetEase (NTES) is trading at is $103.53, which is out of the analyst's predicted range.